Webinar | November 10, 2021

Improving Patient Access To Cell And Gene Therapy

Source: Precision ADVANCE

Improving patient access to cell and gene therapy treatments is the goal of Precision Advance, an initiative of Precision Medicine Group. Precision Advance provides a set of interconnected services and personnel designed to help bring new therapies to market.

Precision Medicine Group made a major investment in Precision Advance earlier in 2021 through the acquisition of Project Farma, a bioengineering services firm that supports life sciences researchers. Learn how specializing in planning and implementing complex biomanufacturing strategies has led to the construction of more than a dozen manufacturing facilities.

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Precision ADVANCE